Clinical trial

Toripalimab Combined With SBRT for NSCLC

NCT06293690

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-04-15

PhasePHASE2

Study timeline

Study start (actual)2024-04-15Date precision: day

Registry last updated2025-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Lung Cancerunresolved

Interventions

ToripalimabDRUG · verified · RxNorm: toripalimab

Sponsors & collaborators

Shanghai Pulmonary Hospital, Shanghai, Chinalead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06293690 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.